Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Sep 2008 15:14

RNS Number : 2159E
Skyepharma PLC
24 September 2008
 



For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Skyepharma PLC GB00B3BFNB64

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

N/A

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

N/A

An event changing the breakdown of voting rights

N/A

Other (please specify): The ISIN for Skyepharma Plc ordinary shares has changed from GB0008123571 to GB00B3BFNB64.

Yes

3. Full name of person(s) subject to notification obligation:

UBS INVESTMENT BANK

4. Full name of shareholder(s) (if different from 3):

UBS AG London Branch

5. Date of transaction (and date on which the threshold is crossed or reached if different):

22 September 2008

6. Date on which issuer notified:

24 September 2008

7. Threshold(s) that is/are crossed or reached:

4.43%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

Direct

Indirect

Direct

Indirect

GB00B3BFNB64

-

-

361,155

361,155

-

4.43%

4.43%

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

-

-

-

-

-

Total (A+B)

Number of voting rights

Percentage of voting rights

361,155

4.43%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Proxy Voting:

10. Name of proxy holder:

-

11. Number of voting rights proxy holder will cease to hold:

-

12. Date on which proxy holder will cease to hold voting rights:

-

13. Additional information:

14 Contact name:

Cintia Goertz/Sarah Cottle

15. Contact telephone number:

0207 5684 981

For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLXZLFLVKBEBBX
Date   Source Headline
22nd Mar 201610:36 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
22nd Mar 201610:00 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
22nd Mar 20169:57 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
21st Mar 20163:13 pmRNSForm 8.3 - Skyepharma plc
21st Mar 20162:47 pmRNSForm 8.3 - [Skyepharma plc]
21st Mar 20161:30 pmRNSForm 8.3 - Skyepharma PLC
21st Mar 201611:45 amRNSForm 8.5 (EPT/RI)
21st Mar 201611:41 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
21st Mar 201611:11 amRNSForm 8.3 - Skyepharma PLC
21st Mar 201611:06 amRNSForm 8.5 (EPT/RI) -Vectura Group PLC
21st Mar 201610:59 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
21st Mar 20167:00 amRNSAdditional Listing
18th Mar 20163:46 pmPRNForm 8 (OPD) - Skyepharma Plc
18th Mar 20163:24 pmRNSForm 8.3 - Skyepharma Plc
18th Mar 20163:01 pmRNSForm 8.3 - Skyepharma Plc
18th Mar 20162:34 pmRNSForm 8.3 - Skyepharma PLC
18th Mar 201612:29 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
18th Mar 201611:14 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
18th Mar 201611:06 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
18th Mar 201611:05 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
18th Mar 201610:02 amRNSHolding(s) in Company
18th Mar 20169:37 amRNSForm 8.3 - Skyepharma PLC
17th Mar 20163:16 pmRNSForm 8.3 - Skyepharma Plc
17th Mar 20163:07 pmRNSForm 8.3 - Skyepharma Plc
17th Mar 20163:00 pmRNSForm 8.3 - Skyepharma PLC
17th Mar 20162:44 pmRNSForm 8.3 - Skyepharma Plc
17th Mar 20162:38 pmRNSForm 8.3 - Skyepharma Plc
17th Mar 20162:14 pmRNSForm 8.3 - Skyepharma plc
17th Mar 20162:08 pmRNSForm 8.3 - [Skyepharma plc]
17th Mar 20161:40 pmRNSForm 8.3 - Skyepharma Plc
17th Mar 201611:45 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
17th Mar 201611:42 amRNSForm 8.5 (EPT/RI) -Vectura Group PLC
17th Mar 201611:39 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
17th Mar 201610:42 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
17th Mar 20169:42 amBUSForm 8.3 - Skyepharma Plc - Ordinary shares
17th Mar 20169:32 amRNSForm 8.3 - Skyepharma PLC
17th Mar 20169:04 amBUSForm 8.3 - Skyepharma
17th Mar 20167:00 amRNSRule 2.10 Announcement
16th Mar 20164:47 pmRNSForm 8.3 - Skyepharma Plc
16th Mar 20161:34 pmRNSForm 8.3 - Vectra Group Plc
16th Mar 20161:29 pmRNSForm 8.3 - Skyepharma Plc
16th Mar 20168:48 amRNSRule 2.7 Announcement - Recommended Merger
16th Mar 20168:45 amRNSFinal Results
4th Mar 20165:40 pmRNSHolding(s) in Company
3rd Mar 20162:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20167:00 amRNSHolding(s) in Company
26th Feb 201610:13 amRNSHome Member State
8th Feb 20167:00 amRNSNotice of Results
5th Feb 20165:25 pmRNSDirector/PDMR Shareholding
2nd Feb 201611:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.